Experts Discuss EU Approach to Addiction Policy in Brussels Meeting

Nov.21.2022
Experts Discuss EU Approach to Addiction Policy in Brussels Meeting
Experts discussed addiction policies in the EU, prioritizing a compassionate approach to help those in need with low-risk products.

Policy-makers and experts in addiction held a meeting in Brussels on November 15th to discuss the best ways to address various addiction issues at the EU level, including alcohol, tobacco, gambling, and digital technology. The meeting focused on Czech Republic's presidency of the EU Council and consensus was reached that the priority should be on implementing a comprehensive, empathetic, and realistic approach to help those in need.


It is unrealistic to have a world without drugs, tobacco, and alcohol, and it may not be beneficial for people's mental health. Stringent regulation has little effect on addictive behavior," National Drug Coordinator Jindrich Voboril was quoted in a press release as saying. "What we can do effectively is to minimize the harm. Addiction policies should allow adults to have access to lower-risk addictive products and allow people to make their own choices.


The roundtable organized by the Rational Addiction Policy Institute also discussed views on addressing addiction issues and the role that EU institutions such as EMCDDA should play in this regard.


The European Parliament has sent a clear message in its report on the European Beating Cancer Plan, emphasizing the importance of practical, evidence-based policies. "The European Union Commission should listen to expert opinions and adopt a rational and science-based approach," stated Member of the European Parliament, Radka Maxova.


Viktor Mravcik, head of the science department at IRAP, presented the example of the Czech Republic, which has successfully implemented a comprehensive harm reduction approach to alcohol and tobacco dependence. In a subsequent discussion, Ales Rod, a member of the National Economic Advisory Council and head of the Economic and Market Analysis Center, spoke about his recent research on best practices in managing tobacco dependence policies in several member countries, including the Czech Republic, as well as Sweden.


If we recognize that a drug-free world is impossible, we should consider the impact of regulation. I also urge Sweden, which is about to take on the presidency of the EU Council, to address these issues as a priority and ultimately help Europeans overcome their addiction problems. After all, Sweden has done a lot in this regard," added Swedish psychologist and addiction expert Carl Fagerstrom.


Statement:


This article is compiled from third-party information and is intended for industry exchange and learning.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the truth or accuracy of the article’s content. The translation of this article is only for industry exchange and research purposes.


Due to limitations in translation skills, the translated article may not fully express the same meaning as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macao, Taiwan or foreign-related expressions and positions.


The copyright for compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
FDA Filing Shows RIF Notices for 229 CTP Employees Were Largely Rescinded
A court declaration signed by FDA official Melanie M. Keller on March 24, 2026 detailed the status of previously issued reduction-in-force notices affecting employees at the Center for Tobacco Products (CTP).
Apr.01 by 2FIRSTS.ai
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
Acting CTP Director Says FDA Cut Premarket Tobacco Application Backlog by About 70% Over the Past Year
FDA Center for Tobacco Products Acting Director Bret Koplow said at the American Tobacco and Nicotine Forum that the agency has reduced its premarket tobacco application backlog by about 70% over the past year and eliminated the acceptance queue. He said FDA has reviewed about 27 million applications, but only a small number have been authorized, mainly because most submissions lacked the scientific data needed to demonstrate public health benefits.
Apr.23 by 2FIRSTS.ai
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
FDA Launches Elsa 4.0 and Completes HALO Data Platform Consolidation
The U.S. Food and Drug Administration announced on May 6 that it has advanced its modernization initiative by launching Elsa 4.0, an upgraded internal AI tool, and consolidating more than 40 application and submission data sources, systems and portals into a new platform called HALO. FDA said the integration of HALO and Elsa will allow staff to query data and build workflows without manually uploading documents in each chat.
May.07 by 2FIRSTS.ai
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS Urges USTR to Address Illegal E-Cigarette Exports in China Trade Engagements
NACS submitted a comment letter to USTR in a proceeding examining unfair trade practices worldwide. The letter focuses on illicit nicotine products made in China and shipped to the United States in violation of U.S. law. NACS said the U.S. electronic nicotine delivery systems market has become dominated by illicit products, mainly disposable e-cigarettes manufactured in China and sold without the marketing authorization required by the U.S. Food and Drug Administration.
Apr.16 by 2FIRSTS.ai
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13